Artiva Biotherapeutics, Inc. Balance Sheet
ARTV|2 years of annual SEC 10-K data (FY2024-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Artiva Biotherapeutics, Inc. had $131M in total assets and $110M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash & Equivalents | $26.7M | $40.2M |
| Current Assets | $112.7M | $188.6M |
| PP&E (Net) | $6.6M | $6.4M |
| Total Assets | $130.9M | $209.6M |
| Current Liabilities | $13.1M | $12.3M |
| Shareholders' Equity | $110.0M | -$162.0M |